Want to join the conversation?
$XYL said deal is expected to add to its adjusted earnings in 2017. $XYL will finance all-cash transaction with deployment of about $400MM of its non-U.S. cash, new and existing credit facilities, and combination of short- and long-term debt. There is no change to $XYL's 2016 adjusted earnings outlook. The transaction is expected to close in 4Q16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?